Evaluation of ESPAIR, an Educational Therapy's Program of Patients With Renal Insufficiency Before Kidney Transplant (ESPAIR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02468440|
Recruitment Status : Completed
First Posted : June 10, 2015
Last Update Posted : April 2, 2019
|Condition or disease||Intervention/treatment||Phase|
|Renal Insufficiency||Other: ESPAIR||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||224 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Evaluation of ESPAIR, an Educational Therapy's Program of Patients With Renal Insufficiency Before Kidney Transplant|
|Actual Study Start Date :||June 2, 2015|
|Actual Primary Completion Date :||January 14, 2019|
|Actual Study Completion Date :||January 14, 2019|
Patients with an educational therapy's program since registration in transplant list.
ESPAIR is an educational therapy's program with 6 group session,and if patients ask for it, individual session are possible
No Intervention: normal care
Patients without educational therapy
- Quality of life Questionnaire [ Time Frame: 6 months ]Quality of life 6 months after registration on transplant list.
- Quality of life Questionnaire [ Time Frame: One year ]Quality of life one year after registration on transplant list.
- Quality of life Questionnaire [ Time Frame: 1 day ]Quality of life on the day of the transplantation
- Composite measure of impact of educational therapy's program [ Time Frame: 6 months ]Impact of educational therapy's program on anxiety, knowledge to prepare transplant, life hygiene, and patient compliance.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02468440
|Principal Investigator:||Laure Esposito, MD||University Hospital, Toulouse|